Related Experiment Video
Updated: Aug 28, 2025
08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.3K
Circular RNAs: New Players in Cardiomyopathy
Maedeh Bagheri Moghaddam1,2, Majid Maleki2, Maziar Oveisee3
1Molecular Genetics Department, Faculty of Biological Sciences, Tarbiat Modares University, Tehran 141171311, Iran.
Genes
|September 23, 2022
Summary
Circular RNAs (circRNAs), a novel class of noncoding RNAs, are increasingly recognized for their critical roles in cardiomyopathies. Research highlights their potential as diagnostic biomarkers and therapeutic targets for these heart muscle disorders.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Genetics
Background:
- Cardiomyopathies are a major cause of heart failure and mortality globally, characterized by myocardial dysfunction.
- Circular RNAs (circRNAs) are stable, noncoding RNA molecules with diverse regulatory functions, including microRNA sponging.
- Emerging evidence suggests circRNAs are implicated in the pathogenesis of various cardiovascular diseases, including cardiomyopathies.
Purpose of the Study:
- To review the classification, characteristics, and functions of circRNAs.
- To summarize recent findings on the role of circRNAs in cardiomyopathies.
- To explore the clinical potential of circRNAs as diagnostic biomarkers and therapeutic targets for cardiomyopathies.
Main Methods:
- Literature review of current research on circRNAs and cardiomyopathies.
- Analysis of studies detailing circRNA classification, function, and involvement in cardiovascular diseases.
- Discussion of the translational potential of circRNAs in clinical settings.
Main Results:
- CircRNAs are abundant, conserved, and play key roles in gene regulation, resistant to degradation.
- Significant roles of circRNAs have been identified in the development and progression of cardiomyopathies.
- circRNAs show promise as potential diagnostic biomarkers and therapeutic targets for cardiomyopathies.
Conclusions:
- circRNAs represent a significant area of research in understanding and treating cardiomyopathies.
- Further investigation into circRNAs could lead to novel diagnostic tools and therapeutic strategies for heart muscle diseases.
Related Concept Videos
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
21
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
21
01:25Cardiomyopathy I: Introduction and Classification
41
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
41
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
37
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
01:30Cardiomyopathy II: Dilated Cardiomyopathy
19
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
01:29Cardiomyopathy V: Interprofessional Care
29
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
01:23Rheumatic Heart Disease I: Introduction
31
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
31